Essential Blood Tests for Women Over 30 in the UAE — Complete Checklist

Complete Blood Count (CBC): The foundational test for women of all ages. Detects iron-deficiency anaemia — particularly important for women with heavy periods (menorrhagia), which affects approximately 20–30% of reproductive-age women. Low haemoglobin causes fatigue, brain fog, and reduced immunity.

Iron Studies (Serum Iron, Ferritin, TIBC): Ferritin is the most sensitive marker of iron stores — a normal haemoglobin does not rule out iron depletion if ferritin is low. Target ferritin for symptom-free women: above 30 ng/mL; ideal above 50 ng/mL. Must fast 10–12 hours.

Thyroid Panel (TSH, FT3, FT4): Thyroid disease — primarily autoimmune hypothyroidism (Hashimoto's disease) — affects 5–10% of women by age 40. Symptoms (fatigue, weight gain, hair loss, cold intolerance, irregular periods) overlap with many other conditions, making thyroid testing essential. TSH alone (contact lab for current pricing) is the standard first-line test; a full panel (contact lab for current pricing) provides more detail.

Vitamin D (25-Hydroxy): Vitamin D deficiency is the most common nutritional deficiency in UAE women. Particularly important for women wearing full-coverage clothing who have minimal sun exposure. Chronic deficiency increases risk of osteoporosis, depression, and immune dysfunction.

Vitamin B12: Deficiency risk is elevated in vegetarian women — a significant segment of UAE's South Asian expat community. Also relevant for women on metformin (for diabetes or PCOS) as it depletes B12.

From age 35, the risk profile shifts to include cardiovascular and metabolic concerns:

Lipid Profile: Cardiovascular disease risk begins climbing in women approaching perimenopause. Oestrogen has a protective effect on cholesterol metabolism; this advantage erodes as oestrogen levels decline. Target LDL below 3.0 mmol/L. Fasting required.

HbA1c: Insulin resistance is a hallmark of PCOS (the most common hormonal disorder in women of reproductive age in the UAE). Annual HbA1c screening catches pre-diabetes early.

AMH (Anti-Müllerian Hormone): From age 32–35, AMH becomes a clinically relevant marker of ovarian reserve for women considering future pregnancy. A declining AMH does not prevent pregnancy but indicates diminishing time to natural conception. No fasting or cycle-day timing required.

Folate (Folic Acid): Women planning pregnancy should have folate checked and supplemented (400–800 mcg/day) at least 3 months pre-conception. Women on oral contraceptives (which depletes folate) benefit from regular monitoring.

Calcium (Serum): Bone density peaks in the late 20s and begins declining from the mid-30s. Adequate calcium is essential. Serum calcium (contact lab for current pricing) does not directly measure bone density but, combined with Vitamin D, guides supplementation decisions.

Polycystic Ovary Syndrome (PCOS) is estimated to affect 10–15% of women of reproductive age in the UAE — one of the highest rates globally, likely related to insulin resistance driven by dietary and lifestyle patterns. PCOS is frequently under-diagnosed because its symptoms (irregular periods, acne, hair thinning, weight gain) are often attributed to other causes.

The PCOS blood test panel includes: Total Testosterone (elevated in PCOS — typically above 0.7 ng/mL or 2.4 nmol/L). DHEAS (Dehydroepiandrosterone sulphate) — adrenal androgen. LH (Luteinising Hormone) and FSH — an LH:FSH ratio above 2:1 supports PCOS diagnosis (should be measured Day 2–4 of cycle). Fasting Insulin and Glucose (to assess insulin resistance — HOMA-IR calculation). AMH (elevated in PCOS — often above 4–5 ng/mL). Thyroid panel and prolactin (to exclude other causes of irregular periods).

None of these tests alone diagnoses PCOS — diagnosis requires the Rotterdam criteria (at least 2 of: irregular ovulation, clinical or biochemical hyperandrogenism, polycystic ovaries on ultrasound). Blood tests provide the 'biochemical hyperandrogenism' component and can prompt ultrasound referral.

From age 40, the recommended panel expands:

CA-125 (Cancer Antigen 125): Ovarian cancer marker. CA-125 is not recommended as a population-wide screening test (low specificity — elevated in endometriosis, fibroids, and other benign conditions) but is appropriate for women with a family history of ovarian cancer or BRCA mutation carriers. CA-125 above 35 U/mL in a postmenopausal woman warrants urgent gynaecology referral.

hs-CRP (High-Sensitivity CRP): Cardiovascular risk in women is often underestimated. hs-CRP above 3 mg/L indicates elevated inflammatory cardiovascular risk. In women, this test adds incremental risk prediction beyond lipid profile.

FSH (Follicle Stimulating Hormone): Rising FSH in women in their early-to-mid 40s indicates perimenopause. FSH above 25 IU/L (measured on day 2–3 of cycle) suggests diminished ovarian reserve; above 40 IU/L in the context of amenorrhoea suggests menopause. This guides discussion with an OB-GYN about fertility windows and HRT.

DEXA scan referral (bone density): Not a blood test, but a key step for women over 45 — request a referral from your GP. Low Vitamin D and calcium should be corrected before DEXA scan.

Medsol Women's Health Panel (contact lab for current pricing): The most comprehensive gender-specific package available at a budget lab. Includes CBC, lipid profile, glucose, LFT, KFT, full thyroid panel, Vitamin D, B12, iron studies, folate, FSH, estradiol, prolactin, and calcium — 82 biomarkers. Excellent value. Add AMH and testosterone separately if PCOS screening is needed.

Al Borg Comprehensive Wellness (contact lab for current pricing): Not gender-specific but covers the core panel well — CBC, lipid, diabetes, LFT, KFT, thyroid, Vitamin D, B12, iron studies. Does not include reproductive hormones (FSH, estradiol, AMH). Add fertility hormone tests for available at competitive rates additional.

DarDoc At-Home Comprehensive (contact lab for current pricing): Ideal for women who prefer home collection. Covers the main metabolic panel with home nurse visit. Add-on tests can be requested at the time of booking.